{"paper_id":"62b93ed4-d377-463c-b76f-29e441a0e7d2","body_text":"~ 240 ~ \n International Journal of Homoeopathic Sciences 2025; 9(1): 240-244 \n \nE-ISSN: 2616-4493 \nP-ISSN: 2616-4485 \nwww.homoeopathicjournal.com \nIJHS 2025; 9(1): 240-244 \nReceived: 16-10-2024 \nAccepted: 18-11-2024 \n \nDr. GR Divya Jyoti Anand \nPG Scholar, Department of \nCase Taking and Repertory, \nNational Institute of \nHomoeopathy, Block- GE, \nSector – III, Salt lake City, \nKolkata, West Bengal, India \n \nDr. Madhu Gautam \nAssistant Professor, \nDepartment of Case taking and \nRepertory, Sumandeep \nHomoeopathic Medical College \nand Hospital, Vadodara, \nGujar, Gujarat, India \n \nDr. C Lalhmangaihsangi \nPG Scholar, Department of \nCase Taking and Repertory, \nNational Institute of \nHomoeopathy, Block- GE, \nSector – III, Salt Lake City, \nKolkata, West Bengal, India \n \nDr. BP Srivastava \nProfessor, Department of Case \ntaking and Repertory National \nInstitute of Homoeopathy \nBlock - GE, Sector –III, Salt \nLake City, Kolkata West \nBengal, India \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nCorresponding Author: \nDr. GR Divya Jyoti Anand \nPG Scholar, Department of \nCase Taking and Repertory, \nNational Institute of \nHomoeopathy, Block- GE, \nSector – III, Salt lake City, \nKolkata, West Bengal, India\n \n \nIndividualized homoeopathic treatment of \nadenomyosis: A case report \n \nDr. GR Divya Jyoti Anand, Dr. Madhu Gautam, Dr. C \nLalhmangaihsangi and Dr. BP Srivastava \n \nDOI: https://doi.org/10.33545/26164485.2025.v9.i1.D.1358  \n \nAbstract \nAdenomyosis is a myometrial lesion characterised by endometrial glands and stroma located \nhaphazardly and deep within the myometrium. The exact cause of the ingrowth of tissues is unknown. \nIt may be due to repeated childbirths, vigorous curettage or excess hormones level. The common \nsymptom is heavy, painful menstrual bleeding, typically occurring in multiparous women. It has an \nassociation with infertility. \nThis case study suggests homoeopathic treatment as a promising complementary or alternative therapy, \nemphasizes the significance of repertorization with Synthesis Repertory and individualized \nhomoeopathic prescription in a patient suffering from Adenomyosis.\n \n \nKeywords: Adenomyosis, homoeopathic treatment, case report, synthesis repertory, repertorization, \nlycopodium \n \nIntroduction \nMost women are suffering from one or more menstrual problems in their lives, Adenomyosis \nis also one among them [1]. Adenomyosis is a common benign gynaecologic disorder that \naffects 8.8-61.5% of women undergoing a hysterectomy and 20-34% of women referred for \npelvic imaging [2, 3]. It is characterised by ectopic endometrial glands or stroma in the uterine \nmyometrium [3, 4]. \nThe first description of the condition initially referred to as “Adenomyoma” was provided in \n1860 by the German pathologist Carl von Rokitansky, who found endometrial glands in the \nmyometrium and subsequently referred to this finding as “cystosarcoma adenoids uterinum”. \nThe modern definition of Adenomyosis was provided in 1972 by Bird who stated: \n“Adenomyosis may be defined as the benign invasion of the endometrium into  the \nmyometrium, producing a diffusely enlarged uterus which microscopically exhibits ectopic \nnon-neoplastic, endometrial glands and stroma surrounded by the hypertrophic and \nhyperplastic myometrium” [5-7]. \nThis condition seems very rare before age 20, a cystic form has mainly been reported in \nyoung women [8]. It’s diagnosis appears more common in women between 40 and 50 years \nold (70-80%) [9]. \nIn India, the prevalence of Adenomyosis is 23.5% of which 80% were seen in the age group \nof 31-50 years [10]. \nAdenomyosis is classified into focal and diffuse based on histopathological examinations, \nfocal is characterised by nodules of endometrial glands, and stroma surrounded by normal \nmyometrium are found in the specimens. Diffuse Adenomyosis is characterised by \nendometrial glands and stroma distributed throughout the myometrium [11]. \nThe aetiology of Adenomyosis is not known. It may be due to repeated childbirths, vigorous \ncurettage, or excess estrogen level [12]. \nRisk factors are middle age, multi-parity, surgical disruptions of the endo-myometrial border, \nelevated levels of both FSH and prolactin (PRL), smoking habits, and history of depression \n[13, 14]. \nIn about 50%, it remains asymptomatic being discovered on histological examination. \nPatients present with some common symptoms:- \n1) Menorrhagia (70%)-heavy menstrual bleeding  \n2) Dysmenorrhea (30%)- pain in the lower abdomen during menses \n3) Dyspareunia-painful coition \n\nInternational Journal of Homoeopathic Sciences https://www.homoeopathicjournal.com \n~ 241 ~ \n4) Frequency of urination due to enlarged and tender \nuterus. \n5) Associated with Infertility [13-17]. \n \nIn a recent cross-sectional study on infertile women, \nAdenomyosis prevalence was 24.4% in women at least 40 \nyears old and 22% less than 40 years old. This percentage \nincreased to 38.2% in cases of recurrent pregnancy loss and \nto 34.7% in previous ART failure [12, 18], whereas, in those \nwith a history of endometriosis, the percentage is widely \nvariable, ranging from 20% to 80% [19, 20, 12]. \nPelvic endometriosis co-exists in about 40 % of cases \n[13], and uterine fibroids [6, 12, 21] . In 15% to 57% of cases, \nuterine Leiomyomas and Adenomyosis coexist in the same \nuterus, and women with both conditions are more likely to \nexperience pelvic pain [12, 22]. \nAs imaging techniques further developed, a non-invasive \napproach for diagnosing Adenomyosis became feasible, \nallowing for the earlier clinical detection of the disease. \nMagnetic Resonance Imaging (MRI) and Transvaginal \nUltrasonography (TVUS) are reported to have similar \nsensitivities and specificities in the detection of \nAdenomyosis and have increasingly been used to identify \nthe presence of Adenomyotic lesions, and to plan \nsubsequent treatment [23, 24] . Three‐Dimensional (3D) TVS \nhas been reported to improve diagnostic accuracy, because it \nenables visualization of changes in the junctional zone in \ngreater detail than Two‐Dimensional (2D) ultrasound [25, 26]. \nThe choice of treatment depends on the woman’s age, \nreproductive status, and clinical symptoms. However, so far, \nfew clinical studies have been performed on medical or \nsurgical treatment for Adenomyosis, and no drugs labelled \nfor Adenomyosis are currently available [27]. \nIt has a negative impact on women’s quality of life in a high \npercentage of cases because of abnormal uterine bleeding \nand pain requiring a lifelong management plan through \nmedical or surgical treatment [28].  \nThe definitive treatment for Adenomyosis is hysterectomy, \nbut this surgical intervention can be avoided through \nindividualized homoeopathic treatment. Various \nhomoeopathic medicines, such as Arsenicum album , Nux \nvomica, Secale cor , Lachesis mutus , Medorrhinum, \nPulsatilla, Sepia officinalis , Thuja, etc., can be useful in \ntreating patients suffering from Adenomyosis [29, 30] . \nHomeopathy can also be integrated into a broader treatment \nplan alongside conventional medical care, providing a \nholistic approach to managing Adenomyosis cases [30]. \n \nCase proper  \nA 27-years-old female, from Murshidabad visited Obs. & \nGyn. OPD of National Institute of Homoeopathy on 22 nd \nMarch 2022. She presented with complaints of excessive \nmenstrual bleeding for the last 3-4 months. \nIt was a known case of Diffuse Uterine Adenomyosis, as \ndetected by USG of the whole abdomen on 30th Jan 2022. \n \nHistory of present complaints  \n1) Excessive menstrual bleeding for the last 3-4 months. \n Cycle: 8-9 days/ 30-34 days  \n Flow-heavy, uses 5-6 pads/ day \n Pain in the lower abdomen during menses (3+) \n Weakness during menses \n \nMenstrual history-menarche at 12 years of age and cycle \nwas 3-4 days/ 28 days \nLMP-19th Feb 2022 \n \nPast history  \n Appendectomy-7 years ago \n Tubectomy-6 years ago \n \nFamily history: Nothing significant  \n \nPersonal history \n1) Addiction-Nothing significant \n2) Diet-Irregular  \n3) Marital status-Got married 13 years ago \n4) Number of children-2 Boys-NVD  \n5) Any regular medication-Nill  \n \nPhysical generals  \n Appetite-Less, 2 times/ day. \n Thirst-less, 1L/ day \n Desire-Mushrooms (3+) \n Aversion-Sour food (3+) \n Intolerance- Nothing significant \n Urine-D (3-4) N (1), no complaints \n Stool-constipation, once in 2-3 days. \n Perspiration-Moderate, no staining and no odour  \n Sleep-delay but sound sleep  \n Dreams-Dreams of wild animals  \n Thermal reaction-Hot  \n Tongue-Cracked, moist and clean. \n \nMental generals  \n Easily gets offended  \n Irritated mood due to health issue  \n Likes to stay with people \n Consolation aggravation  \n Anxiety about her health  \n \nAnalysis & evaluation of symptoms  \n \nS. \nNo. Symptoms Common/ \nUncommon Grade \nEasily gets offended  Uncommon 3 \nIrritated mood due to health issue Common 2 \nLikes to stay with people Uncommon 3 \nConsolation aggravation  Uncommon 3 \nAnxiety about her health  Uncommon 1 \nLess appetite Common 3 \nLess thirst  Common 1 \nAversion to sour food Uncommon 3 \nDesire for mushrooms Uncommon  3 \nConstipation  common 2 \nModerate Perspiration Common 1 \nDelay but sound sleep Common 1 \nDreams of wild animals  Uncommon 3 \nThermal reaction is hot  Common 3 \nCracked tongue Uncommon 3 \nExcessive menstrual bleeding  Common 3 \nPain in lower abdomen during \nmenses Common  3 \nWeakness during menses Uncommon 3 \nMenses last for 8-9 days Uncommon  3 \n  \n\nInternational Journal of Homoeopathic Sciences https://www.homoeopathicjournal.com \n~ 242 ~ \nTotality of symptoms \na) Likes to stay with people \nb) Consolation aggravation  \nc) Easily gets offended \nd) Less appetite \ne) Aversion to sour food \nf) Desire for mushrooms  \ng) Dreams of wild animals  \nh) Thermal reaction is hot  \ni) Cracked tongue \nj) Excessive menstrual bleeding  \nk) Pain in lower abdomen during menses \nl) Weakness during menses \nm) Menses last for 8-9 days \n \nSelection of repertory \nSynthesis Repertory was selected on the basis of totality of \nsymptoms.  \n \nConversion of symptoms into rubrics  \n \nS. No. Symptoms  Chapters  Rubrics \n1. Likes to stay with people Mind MIND- Company- desire or \n2. Consolation aggravation  Mind MIND- Consolation-agg. \n3. Easily gets offended Mind MIND-Offended-easily \n4. Less appetite Stomach STOMACH-Appetite-wanting  \n5. Aversion to sour food Generals GENERALS-Food and Drinks-sour food- aversion \n6. Desire for mushrooms  Generals GENERALS-Food and Drinks-Mushrooms- desire \n7. Dreams of wild animals  Dreams  DREAMS-Animals-wild \n8. Thermal reaction is hot  Generals GENERALS- Warms-agg. \n9. Cracked tongue Mouth  MOUTH-Cracked-tongue fissured  \n10. Excessive menstrual bleeding  Female genitalia/ Sex FEMALE GENITALIA/ SEX-Menses-copious  \n11. Pain in lower abdomen during menses Female genitalia/ Sex ABDOMEN- Pain- Menses during \n12. Menses last for many days Female genitalia/ Sex FEMALE GENITALIA/ SEX-Menses- protracted- eight to nine days  \n13. Weakness during menses GENERALS  GENERALS-Weakness-Menses \n \nRepertorization [31] \n \n \n \nRepertorial result \n1. Lycopodium-22/ 11 \n2. Nux Vomica-19/ 10 \n3. Sulphur-19/10 \n4. Natrum Muriaticum -21/ 9 \n \nThis case was repertorized with the help of Synthesis \nRepertory using RADAR. The repertorial result was \nanalysed, giving more priority to mental symptoms as well \nas physical general symptoms for selection. According to \nrepertorization, the most indicated remedy was \nLycopodium. \n \nPrescription  \nAfter considering the totality of symptoms and analysing the \nrepertorial result, Lycopodium 0/1, 16 doses of each \npotency was prescribed in 100 ml of aqua dist. Orally, on \nalternate days for 32 days. The potency was gradually \nincreased up to Lycopodium 0/11 with the improvement of \nsymptoms during menses and other symptoms.  \n\nInternational Journal of Homoeopathic Sciences https://www.homoeopathicjournal.com \n~ 243 ~ \n \n  \n \n Before treatment  After treatment  \n \nDiscussion  \nHomoeopathic treatment of Adenomyosis, a case report of a \npatient who was suffering from pain in the lower abdominal \nregion with profuse menstrual bleeding. This case was \npresented with radiological evidence (USG) of a bulky \nuterus, irregular endo-myometrial junction and the presence \nof a small sub-endometrial cyst posteriorly. After proper \ncase taking, Lycopodium was prescribed based on the \ntotality of symptoms with the help of Synthesis Repertory \n[Radar opus version 3.1.5]. Lycopodium 0/1 to Lycopodium \n0/11, 16 doses of each potency on alternate days were \nadministered to the patient. The medicine was given in fifty \nmillesimal potency. The patient started feeling better after a \nfew months of treatment as the intensity of pain and flow of \nmenstrual blood decreased with the relief of other \nsymptoms. The patient was completely cured after eleven \nmonths of treatment. \nAdenomyosis responded well to individualized \nhomoeopathic medicine after repertorization with Synthesis \nRepertory. In this case report, homoeopathic treatment is \nrecommended as a promising complementary or alternative \ntherapy.  \n \nConclusion  \nA 27-year-old lady from Murshidabad visited Obs. & Gyn. \nOPD of National Institute of Homoeopathy on 22 nd March \n2022, presented with complaints of excessive menstrual \nbleeding for the last 3-4 months. Menstrual cycle flow was \nheavy for 8-9 days. It was a known case of Diffuse Uterine \nAdenomyosis, as detected by USG of the whole abdomen \non 30 th Jan 2022. After proper case-taking and \nrepertorization with the help of Synthesis Repertory, \nLycopodium was selected. Lycopodium 0/1 to 0/11, 16 \ndoses of each potency on alternate days were administered \nto the patient based on the totality of symptoms. The patient \nwas completely cured after 11 months of treatment. This \ncase report also emphasises the significance of \nrepertorization with Synthesis Repertory and individualized \nhomoeopathic prescription in a patient suffering from \nAdenomyosis. \n \nReferences  \n1. Shivakumaraswamy P, et al. Ayurvedic management of \nadenomyosis-A case report. Int Ayurvedic Med J., \n2021. \n2. Kho KA, Chen JS, Halvorson LM. Diagnosis, \nevaluation, and treatment of adenomyosis. JAMA. \n2021;326(2):177-178. \n3. Shi J, Wu Y, Li X, et al . Effects of localization of \nuterine adenomyosis on clinical features and pregnancy \noutcome. Sci Rep. 2023;13:14714. \n4. Lax S. Mesenchymal uterine tumors. Stromal tumors \nand other rare mesenchymal neoplasms. Pathologe. \n2009;30(4):284-291. \n5. Taran FA, Stewart EA, Brucker S. Adenomyosis: \nepidemiology, risk factors, clinical phenotype and \nsurgical and interventional alternatives to hysterectomy. \nGeburtshilfe Frauenheilkd. 2013;73(9):924-931. \nDOI:10.1055/s-0033-1350840. \n6. Benagiano G, Brosens I. History of adenomyosis. Best \nPract Res Clin Obstet Gynaecol. 2006;20(4):449-463. \nDOI: 10.1016/j.bpobgyn.2006.01.007. \n7. Renner SP, Lermann J, Hackl J, et al . Chronische \nErkrankung. Endometriose. Geburtsh Frauenheilk. \n2012;72:914-919. \n8. Brosens I, Gordts S, Habiba M, Benagian o G. Uterine \ncystic adenomyosis: a disease of younger women. J \nPediatr Adolesc Gynecol. 2015;28(6):420-426. \n9. Pados G, Gordts S, Sorrentino F, et al . Adenomyosis \nand infertility: A literature review. Medicina (Kaunas). \n\nInternational Journal of Homoeopathic Sciences https://www.homoeopathicjournal.com \n~ 244 ~ \n2023;59(9):1551. DOI:10.3390/medicina59091551. \n10. Sharma R. A case report on Ayurvedic management in \nadenomyosis. J Ayu Int Med Sci. 2022;7(11):191-194. \n11. Vannuccini S, Petraglia F. Recent advances in \nunderstanding and managing adenomyosis. F1000Res. \n2019;8:283. \n12. Konar H. DC Dutta’s textbook of gynec ology. 8th ed. \nJP Medical Ltd, 2020. \n13. Parazzini F, Panazza S, Chatenoud L, et al. Risk factors \nfor adenomyosis. Hum Reprod. 1997;12:1275-1279. \nDOI:10.1093/humrep/12.6.1275. \n14. Taran FA, Weaver AL, Coddington CC, Stewart EA. \nUnderstanding adenomyosis: a case-control study. \nFertil Steril, 2009.  \nDOI: 10.1016/j.fertnstert.2009.06.049. \n15. Peric H, Fraser IS. The symptomatology of \nadenomyosis. Best Pract Res Clin Obstet Gynaecol. \n2006;20(4):547-555.  \nDOI: 10.1016/j.bpobgyn.2006.01.006. \n16. Naftalin J, Hoo W, Pateman K, et al. How common is \nadenomyosis? A prospective study of prevalence using \ntransvaginal ultrasound in a gynecology clinic. Hum \nReprod. 2012;27:3432-3439.  \nDOI: 10.1093/humrep/des332. \n17. Azziz R. Adenomyosis: Current perspectives. Obstet \nGynecol Clin North Am. 1989;16(1):221-235. \n18. Puente JM, Fabris A, Patel J, et al . Adenomyosis in \ninfertile women: Prevalence and the role of 3D \nultrasound as a marker of severity of the disease. \nReprod Biol Endocrinol. 2016;14(1):60. \n19. Donato DN, Montanari G, Benfenati A, et al . \nPrevalence of adenomyosis in women undergoing \nsurgery for endometriosis. Eur J Obstet Gynecol \nReprod Biol. 2014;181:289-293. \n20. Eisenberg VH, Arbib N, Schiff E, et al . Sonographic \nsigns of adenomyosis are prevalent in women \nundergoing surgery for endometriosis and may suggest \na higher risk of infertility. Biomed Res Int. \n2017;2017:8967803. \n21. Brucker SY, Huebner M, Wallwiener M, et al. Clinical \ncharacteristics indicating adenomyosis coexisting with \nleiomyomas: A retrospective, questionnaire-based \nstudy. Fertil Steril. 2014;101(1):237-41.e1. DOI: \n10.1016/j.fertnstert.2013.09.038. \n22. Taran FA, Weaver AL, Coddington CC, et al . \nCharacteristics indicating adenomyosis coexisting with \nleiomyomas: A case-control study. Hum Reprod. \n2010;25(5):1177-1182. \n23. Dueholm M, Lundorf E. Transvaginal ultrasound or \nMRI for diagnosis of adenomyosis. Curr Opin Obstet \nGynecol. 2007;19:505-512.  \nDOI: 10.1097/GCO.0b013e3282f1bf00. \n24. Moawad G, Fruscalzo A, Youssef Y, et al . \nAdenomyosis: an updated review on diagnosis and \nclassification. J Clin Med. 2023;12(14):4828. DOI: \n10.3390/jcm12144828. \n25. Tellum T, Nygaard S, Lieng M. Noninvasive diagnosis \nof adenomyosis: A structured review and meta-analysis \nof diagnostic accuracy in imaging. J Minim Invasive \nGynecol. 2020;27:408-18.e3. \n26. Harmsen MJ, Bosch VDT, Leeuw DRA, et al . \nConsensus on revised definitions of Morphological \nUterus Sonographic Assessment (MUSA) features of \nadenomyosis: results of modified Delphi procedure. \nUltrasound Obstet Gynecol. 2022;60(1):118-131. DOI: \n10.1002/uog.24786. \n27. Vannuccini S, Luisi S, Tosti C, et al. Role of medical \ntherapy in the management of uterine adenomyosis. \nFertil Steril. 2018;109(3):398-405.  \nDOI: 10.1016/j.fertnstert.2018.01.013. \n28. Tosti C, Troìa L, Vannuccini S, et al . Current and \nfuture medical treatment of adenomyosis. JE. \n2016;8:127-135. DOI: 10.5301/je.5000261. \n29. Salauddin M, Singh PK, Singh S, Chhabra APS. \nAdenomyosis and its homoeopathic management. Int J \nHomoeopath Sci. 2020;4(4):15-16. \n30. Pandey S. A case report on adenomyosis. J Ayu Int \nMed Sci., 2024. \n31. Synthesis Repertory (RADAR opus 3.1.5). \n \n \nHow to Cite This Article \nAnand GRDJ, Gautam M, Lalhmangaihsangi C, Srivastava BP.  \nIndividualized homoeopathic treatment of adenomyosis: A case \nreport. International Journal of Homoeopathic Sciences . \n2025;9(1):240-244. \n \n \nCreative Commons (CC) License \nThis is an open-access journal, and articles are distributed under the \nterms of the Creative Commons Attribution-Non Commercial-Share \nAlike 4.0 International (CC BY-NC-SA 4.0) License, which allows \nothers to remix, tweak, and build upon the work non-commercially, \nas long as appropriate credit is given and the new creations are \nlicensed under the identical terms.","source_license":"CC0","license_restricted":false}